Our Charter & Impact Report Join the movement to fix capitalism Careers Help more founders take their shot Knowledge Base Fundraising & Investing, Explained Blog Latest news & updates Press Wefunder in the news Help Center FAQs and support

Log in or Sign Up

Explore Vault

Learn

Our Charter & Impact Report Join the movement to fix capitalism Careers Help more founders take their shot Knowledge Base Fundraising & Investing, Explained Blog Latest news & updates Press Wefunder in the news Help Center FAQs and support

Login or Sign Up

BioClonetics Antibody Effectively Neutralizes 95% of HIV Isolates | BioClonetics Immunotherapeutics

https://wefunder.com/feed/92108

Published at: 2018-07-05 17:45:13 UTC

Author: Katie Kobetsky

Subject: BioClonetics Immunotherapeutics

This update was originally written by BioClonetics CEO/President Charles Cotropia BioClonetics is validating its anti-HIV monoclonal antibody technology having now produced quantity and quality sufficient recombinant antibodies for neutr...

Founders

Community Round Private Round Investor Warmup Pricing Case Studies Verticals Legal Primer Founder Playbook

Syndicates & Funds

Syndicate Fund SPV

Learn

Charter & Impact Report Careers Knowledge Base Blog Press Help Center

Platform

API & Agents Invest Explore Vault

Wefunder means Wefunder Inc and its subsidiaries: Wefunder Advisors LLC, Capitalize Advisors LLC, and Wefunder Portal LLC. This page is hosted by Wefunder Inc.

Wefunder Portal LLC is a member of the Financial Industry Regulatory Authority (FINRA). Wefunder Portal LLC is located in Gun Barrel City, Texas.

Investing is risky. You could lose all your money. Only invest what you can afford to lose. Most investments are hard to sell, and there's no promise you'll get your money back or make a profit. Wefunder does not offer investment advice. Do your own research.

Important Disclosures Terms Privacy Cookies